The mechanisms of successful long-term vein graft adaptation to the arterial environment without excessive intimal thickening are still not completely understood. Several members of the Ephrin-Eph pathway have recently been described as developmentally specified critical determinants of vessel identity, with Ephrin- B2 ligand an embryonic determinant of arteries and Eph-B4 receptor an embryonic determinant of veins. We have recently shown in both humans and rats that diminished Eph-B4 expression and loss of venous identity is associated with intimal thickening during vein graft adaptation, and that VEGF-A is an upstream inhibitor of intimal thickening. In addition, we showed increased amounts of the vasculoprotective protein Nogo-B during both human and rat vein graft adaptation. However, it is currently not established whether plasticity exists in vessel specification genes in adults, whether the Ephrin-Eph pathway plays a mechanistic role during vein graft adaptation to the arterial environment, or whether Nogo-B is linked to Eph-B4 signaling pathways. We present our exciting new data that: 1) diminished Eph-B4 gene expression and immunoreactive protein is associated with intimal thickening in the mouse model of vein graft adaptation;2) we can manipulate Eph-B4 signaling in vivo to directly test the role of Eph-B4 in vein graft adaptation in mice;3) Nogo-B inhibits intimal thickening during vein graft adaptation;and 4) Nogo-B protein is increased in vein grafts treated with siRNA directed against VEGF-A, linking the Nogo-B pathway with the VEGF-A-Eph-B4 pathway. We hypothesize that decreased expression of venous specification genes without concomitant expression of arterial specification genes leads to excessive intimal thickening, and ultimately vein graft failure. We will test our hypothesis with the following specific aims:
Aim I. To determine whether Eph-B4 signaling mediates intimal thickening during vein graft adaptation.
Aim II. To determine whether VEGF-A inhibition of intimal thickening is mediated by regulation of vessel identity and Eph-B4 expression.
Aim III. To determine whether the vasculoprotective effects of Nogo-B during vein graft adaptation are mediated by regulation of Eph-B4 function. The studies are innovative in that analyses of vein graft identity have not been previously performed in mice, and plasticity of the Eph-B4 pathway has not been previously demonstrated in adults. At the completion of these studies, we expect to identify a role for Eph-B4 in vein graft adaptation and to determine whether strategies to limit intimal thickening during vein graft adaptation by altering vessel identity will be a novel approach for a human clinical trial.

Public Health Relevance

Significant numbers of surgically placed coronary and peripheral vein grafts continue to fail due to excessive intimal thickening with resultant patient morbidity and mortality. Improving results of long-term myocardial revascularization and limb salvage remain critically dependent on understanding the mechanisms of excessive intimal thickening during vein graft adaptation to the arterial environment. This proposal takes a novel approach, manipulation of vessel identity, to control intimal thickening.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Bioengineering, Technology and Surgical Sciences Study Section (BTSS)
Program Officer
Reid, Diane M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Schools of Medicine
New Haven
United States
Zip Code
Hall, Michael R; Yamamoto, Kota; Protack, Clinton D et al. (2015) Temporal regulation of venous extracellular matrix components during arteriovenous fistula maturation. J Vasc Access 16:93-106
Bai, Hualong; Kuwahara, Go; Wang, Mo et al. (2014) Pretreatment of pericardial patches with antibiotics does not alter patch healing in vivo. J Vasc Surg :
Model, Lynn S; Hall, Michael R; Wong, Daniel J et al. (2014) Arterial shear stress reduces eph-b4 expression in adult human veins. Yale J Biol Med 87:359-71
Hall, Michael R; Protack, Clinton D; Assi, Roland et al. (2014) Metabolic syndrome is associated with type II endoleak after endovascular abdominal aortic aneurysm repair. J Vasc Surg 59:938-43
Lu, Daniel Y; Chen, Elizabeth Y; Wong, Daniel J et al. (2014) Vein graft adaptation and fistula maturation in the arterial environment. J Surg Res 188:162-73
Wong, Daniel J; Lu, Daniel Y; Protack, Clinton D et al. (2014) Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro. J Vasc Surg :
Curci, John A; Kraiss, Larry; Dalman, Ronald L et al. (2013) The Vascular Research Initiatives Conference and over 25 years of conversations on the science of vascular disease. J Vasc Surg 57:501-7
Indes, Jeffrey E; Muhs, Bart E; Dardik, Alan (2013) First long-term evidence supporting endovascular repair of abdominal aortic aneurysms. Expert Rev Cardiovasc Ther 11:399-402
Yang, Chenzi; Guo, Yuanyuan; Jadlowiec, Caroline C et al. (2013) Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells. J Surg Res 183:478-86
Orozco-Sevilla, Vicente; Naftalovich, Rotem; Hoffmann, Thomas et al. (2013) Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery. J Vasc Surg 58:1360-5

Showing the most recent 10 out of 23 publications